Robert B. Jennings M.D.

[PDF] Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988 Robert B. Jennings M.D., Keith A. Reimer M.D., Ph.D. (auth.), Joel Morganroth, E. Neil Moore (eds.)